Literature DB >> 26762907

Who Is Thrombogenic: The Scaffold or the Doctor? Back to the Future!

Antonio Colombo1, Neil Ruparelia2.   

Abstract

Keywords:  bioresorbable scaffold; drug-eluting stent(s); thrombosis

Mesh：

Substances：

Year:  2016        PMID： 26762907     DOI： 10.1016/j.jcin.2015.09.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  6 in total

1.  How far have we come with bioresorbable vascular scaffolds, and where should we go?

Authors:  Jeehoon Kang; Kyung Woo Park; Hyo Soo Kim
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

2.  Bioresorbable scaffolds and drug-eluting balloons for the management of spontaneous coronary artery dissections.

Authors:  Vasileios F Panoulas; Alfonso Ielasi
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Management of Percutaneous Coronary Intervention Complications.

Authors:  Gregory Means; Christopher End; Prashant Kaul
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

Review 4.  Bioresorbable vascular scaffolds - basic concepts and clinical outcome.

Authors:  Ciro Indolfi; Salvatore De Rosa; Antonio Colombo
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

5.  Comparison of the Absorb bioresorbable vascular scaffold to the Xience durable polymer everolimus-eluting metallic stent in routine clinical practice: a propensity score-matched analysis from a multicenter registry.

Authors:  Bartłomiej Orlik; Krzysztof Milewski; Kamil Derbisz; Michał Jelonek; Patrycja Chrząszcz; Sonia Beil; Adam Młodziankowski; Wojciech Picheta; Piotr P Buszman; Paweł E Buszman
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-06-19       Impact factor: 1.426

6.  Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.

Authors:  Osung Kwon; Jung-Min Ahn; Do-Yoon Kang; Se Hun Kang; Pil Hyung Lee; Soo-Jin Kang; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park; Duk-Woo Park; Seung-Jung Park
Journal:  Korean J Intern Med       Date:  2017-11-07       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.